OSWALDO EMMANUEL ROBLES MIRANDA

Mr. OSWALDO EMMANUEL ROBLES MIRANDA

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2024 in Water
Verified
Journal Article
Open access
PDF file
Miguel Mauricio Aguilera FloresMiguel Mauricio Aguilera Flores
Miguel Mauricio Aguilera Flores
OSWALDO EMMANUEL ROBLES MIRANDAOSWALDO EMMANUEL ROBLES MIRANDA
OSWALDO EMMANUEL ROBLES MIRANDA
NMNahum Medellin
Nahum Medellin
VVVerónica Ávila Vázquez
Verónica Ávila Vázquez
OMOmar Sánchez Mata
Omar Sánchez Mata
CCCAROLINA ESTEFANÍA CHÁVEZ-MURILLO
CAROLINA ESTEFANÍA CHÁVEZ-MURILLO
This study evaluated the potential of a biocoagulant produced from prickly pear peel waste valorization and its use as a biocoagulant aid mixed with aluminum sulfate to remove turbidity in domestic wastewater. A central composite design (CCD) and a simplex lattice design (SLD) of two components (biocoagulant and aluminum sulfate) were developed to determine the optimal doses and pH of the biocoagulant and optimal mixing proportions. Both designs optimized the coagulation process from an analysis of variance to fit the experimental data to mathematical models and an optimization analysis to obtain the highest percentage of turbidity removal. The results showed that a water pH of 4 and a biocoagulant dose of 100 mg/L are optimal conditions for a turbidity removal of 76.1%. The potential decreases to 51.7% when the wastewater pH is maintained at 7.8 and a dose of 250 mg/L is used. This efficiency could be increased to 58.2% by using a mixture with optimal proportions of 30% biocoagulant and 70% aluminum sulfate. The experimental data were fitted to two quadratic models, estimating model prediction errors of 0.42% and 2.34%, respectively. Therefore, these results support the valorization of prickly pear peel waste to produce a biocoagulant, which could be used in acid and alkaline wastewater or as a biocoagulant aid mixed with aluminum sulfate.

30 April 2024 in Environmental Technology
Verified
Journal Article
Closed access
Miguel Mauricio Aguilera FloresMiguel Mauricio Aguilera Flores
Miguel Mauricio Aguilera Flores
OSWALDO EMMANUEL ROBLES MIRANDAOSWALDO EMMANUEL ROBLES MIRANDA
OSWALDO EMMANUEL ROBLES MIRANDA
VVVerónica Ávila Vázquez
Verónica Ávila Vázquez
NMNahum Medellin
Nahum Medellin
OMOmar Sánchez Mata
Omar Sánchez Mata
LÁZARO ADRIÁN GONZÁLEZ FERNÁNDEZLÁZARO ADRIÁN GONZÁLEZ FERNÁNDEZ
LÁZARO ADRIÁN GONZÁLEZ FERNÁNDEZ
This study evaluated the effectiveness of a natural coagulant based on common mallow (Malva sylvestris) to remove turbidity in urban wastewater. A 22 factorial design was selected to determine the optimal dose and the working pH of the natural coagulant. Its potential was studied in 50.0-450 mg/L and 4.00-10.0 ranges of doses and pH, respectively. A simplex lattice mixture evaluated its effectiveness as a coagulant aid combined with aluminum sulfate (conventional coagulant). Mixture proportions 0.000-1.00 were studied for each component, finding the proportion more effective. Results showed that the coagulation treatment could be feasible since a turbidity removal efficiency of 73.7% can be achieved under optimal conditions (50.0 mg/L and pH of 10.0). Likewise, a turbidity removal of 58.9% is obtained using 250 mg/L and maintaining wastewater pH (7.45). This efficiency can be increased using 31.0% natural coagulant mixed with 69.0% aluminum sulfate at 250 mg/L without modifying the wastewater pH. This improvement was associated with the natural coagulant's high molecular weight and long-chained structure since these properties enhance settling time, floc size and strength, and low sludge production. These results support using common mallow as a natural coagulant, making its use more feasible in alkaline water pH or as a coagulant aid combined with aluminum sulfate for urban wastewater treatment. A cost of USD 370/Kg of natural coagulant was estimated, which is higher than conventional coagulants. However, a cost-effectiveness analysis of its implementation should be performed since process scaling costs could significantly reduce its price.